1-2 of 2
Eyal Breitbart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors

Andrew J. Brenner, Yael C. Cohen, Eyal Breitbart, Livnat Bangio, John Sarantopoulos, Francis J. Giles, Ernest C. Borden, Dror Harats, Pierre L. Triozzi
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2013) 19 (14): 3996–4007.
https://doi.org/10.1158/1078-0432.CCR-12-2079
Published: 15 July 2013
View article titled, Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors
Open the PDF for Phase I Dose-Escalation Study of VB-111, an Antiangiogenic Virotherapy, in Patients with Advanced Solid Tumors in another window
Journal Articles

Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats

Michael Peled, Aviv Shaish, Avi Katav, Shoshana Greenberger, Iris Barshack, Reshef Tal, Livnat Bangio, Eyal Breitbart, Dror Harats
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (5): 1664–1673.
https://doi.org/10.1158/1078-0432.CCR-08-1670
Published: 27 February 2009
View article titled, Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats
Open the PDF for Systemic Administration of a Conditionally Replicating Adenovirus, Targeted to Angiogenesis, Reduced Lung Metastases Burden in Cotton Rats in another window
Includes: Supplementary data